Clinical Trial Update: RN1201 Injection in the Treatment of Antibody-Mediated Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial update for RN1201 Injection targeting antibody-mediated platelet disorders. The study includes refractory immune-mediated platelet transfusion ref…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia
• Platelet Transfusion Refractoriness

Drugs mentioned

• RN1201

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia | Phase 1 | Status: NOT_YET_RECRUITING